Target intelligence / Profile preview

Intestinal barrier repair

Molecular classification
Other
01

Overview

Intestinal barrier repair refers to the complex, highly regulated physiological process by which the gastrointestinal tract restores epithelial integrity following injury, inflammation, or infection. The process involves rapid migration and proliferation of intestinal epithelial cells (IECs), restoration of tight junction proteins (such as claudins, occludin, and zonula occludens-1), enhanced secretion of mucus by goblet cells, and regulated interaction with immune cells, growth factors (e.g., epidermal growth factor, amphiregulin, interleukin-33), and the gut microbiota. Tight junction repair, immune-modulation, and cytokine signaling (including IL-10, TGF-β) are critical to effective restoration of mucosal homeostasis. Impairment in these repair mechanisms is linked to pathogenesis of chronic inflammatory conditions such as inflammatory bowel disease, celiac disease, and other gastrointestinal disorders. "Intestinal barrier repair" should not be considered a distinct molecular target; it is a multi-faceted biological response involving the interplay of numerous cell types, receptors (e.g., GLP-2 receptor, EGFR, cytokine receptors), molecular pathways (e.g., Wnt, Notch, NF-κB), and structural proteins within the intestinal mucosa.

Other names
Regeneration of intestinal barrierMucosal healingEpithelial repairRestitution of gut barrier
02

Mechanism of action

Promoting epithelial cell proliferation, migration, and differentiation; Enhancing/Upregulating tight junction proteins; Suppressing/Downregulating pro-inflammatory signaling pathways (e.g., NF-κB/MLCK/MLC); Modulating the balance of pro- and anti-inflammatory cytokines, including stimulation of anti-inflammatory ones; Inducing secretion of protective growth factors and supporting mucus layer integrity and epithelial restitution.

03

Biological functions

Epithelial regenerationWound healingBarrier function maintenanceImmune regulationRestoration of paracellular integrity
04

Disease associations

Inflammatory bowel diseaseCeliac diseaseFood allergyInfectionOther gastrointestinal disorders
05

Safety considerations

Potential for excessive epithelial proliferation leading to dysplasiaInterference with normal immune surveillanceRisk of infection if barrier function is incompletely restored
06

Interacting drugs

Glucagon-like peptide-2 (GLP-2) analogs

9 more in the full profile.

07

Biomarkers

OccludinClaudinZonula occludens-1 (ZO-1)GLP-2 levelsMucin 2 (MUC2)Plasma lipopolysaccharide (LPS)

Beyond the preview

Go deeper on Intestinal barrier repair.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal barrier repair.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call